-
Autor
Anker, Markus S 1 Asteggiano, Riccardo 1 Barberis, Vassilis 1 Bax, Jeroen 1 Belenkov, Yury 1 Bergler-Klein, Jutta 1 Bucciarelli-Ducci, Chiara 1 Chioncel, Ovidiu 1 Coats, Andrew J S 1 Cohen-Solal, Alain 1 Cosyns, Bernard 1 Edvardsen, Thor 1 Farmakis, Dimitrios 1 Flachskampf, Frank A 1 Gaemperli, Oliver 1 Galderisi, Maurizio 1 Grapsa, Julia 1 Haegler-Laube, Eva 1 Heymans, Stephane 1 Hulot, Jean-Sébastien 1
-
Pracoviště
1 M Sechenov's 1st Moscow State Medic... 1 1st Department of Medicine Cardioangi... 1 American Medical Center American Hear... 1 Baker Heart and Diabetes Institute Me... 1 Berlin Institute of Health Center for... 1 Bristol Heart Institute Bristol NIHR ... 1 CIBERCV Instituto de Salud Carlos 3 M... 1 Cardio Oncology Clinic Heart Failure ... 1 Cardio Oncology Service Royal Brompto... 1 Cardiologist in Practice Turin Italy 1 Cardiology Clinical Academic Group St... 1 Cardiology Department La Paz Universi... 1 Cardiology Department Military Hospit... 1 Cardiology Department University Hosp... 1 Clinic of Cardiac and Vascular Diseas... 1 DZHK partner site Berlin 1 DZHK partner site Berlin Berlin Germany 1 Department of Advanced Biomedical Sci... 1 Department of Cardiac Magnetic Resona... 1 Department of Cardiology CARIM School... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
-
Autor
Anker, Markus S 1 Asteggiano, Riccardo 1 Barberis, Vassilis 1 Bax, Jeroen 1 Belenkov, Yury 1 Bergler-Klein, Jutta 1 Bucciarelli-Ducci, Chiara 1 Chioncel, Ovidiu 1 Coats, Andrew J S 1 Cohen-Solal, Alain 1 Cosyns, Bernard 1 Edvardsen, Thor 1 Farmakis, Dimitrios 1 Flachskampf, Frank A 1 Gaemperli, Oliver 1 Galderisi, Maurizio 1 Grapsa, Julia 1 Haegler-Laube, Eva 1 Heymans, Stephane 1 Hulot, Jean-Sébastien 1
-
Pracoviště
1 M Sechenov's 1st Moscow State Medic... 1 1st Department of Medicine Cardioangi... 1 American Medical Center American Hear... 1 Baker Heart and Diabetes Institute Me... 1 Berlin Institute of Health Center for... 1 Bristol Heart Institute Bristol NIHR ... 1 CIBERCV Instituto de Salud Carlos 3 M... 1 Cardio Oncology Clinic Heart Failure ... 1 Cardio Oncology Service Royal Brompto... 1 Cardiologist in Practice Turin Italy 1 Cardiology Clinical Academic Group St... 1 Cardiology Department La Paz Universi... 1 Cardiology Department Military Hospit... 1 Cardiology Department University Hosp... 1 Clinic of Cardiac and Vascular Diseas... 1 DZHK partner site Berlin 1 DZHK partner site Berlin Berlin Germany 1 Department of Advanced Biomedical Sci... 1 Department of Cardiac Magnetic Resona... 1 Department of Cardiology CARIM School... 1
- Formát
- Publikační typ
- Check Tag
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
- Čelutkienė, Jelena
- Pudil, Radek
- López-Fernández, Teresa
- Grapsa, Julia
-
Nihoyannopoulos, Petros
Autor Nihoyannopoulos, Petros Unit of Inherited Cardiovascular Diseases/Heart Center of the Young and Athletes, First Department of Cardiology, Hippokrateion General Hospital, National and Kapodistrian University of Athens, Athens, Greece National Heart and Lung Institute Imperial College London, Hammersmith Hospital, London, UK
- Bergler-Klein, Jutta
- Cohen-Solal, Alain
- Farmakis, Dimitrios
- Tocchetti, Carlo Gabriele
- von Haehling, Stephan
PubMed
32621569
DOI
10.1002/ejhf.1957
Knihovny.cz E-zdroje
Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position statement examines the role of echocardiography, cardiac magnetic resonance, nuclear cardiac imaging and computed tomography in the management of cancer patients. The Imaging and Cardio-Oncology Study Groups of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the ESC have evaluated the current evidence for the value of modern CV imaging in the cardio-oncology field. The most relevant echocardiographic parameters, including global longitudinal strain and three-dimensional ejection fraction, are proposed. The protocol for baseline pre-treatment evaluation and specific surveillance algorithms or pathways for anthracycline chemotherapy, HER2-targeted therapies such as trastuzumab, vascular endothelial growth factor tyrosine kinase inhibitors, BCr-Abl tyrosine kinase inhibitors, proteasome inhibitors and immune checkpoint inhibitors are presented. The indications for CV imaging after completion of oncology treatment are considered. The typical consequences of radiation therapy and the possibility of their identification in the long term are also summarized. Special populations are discussed including female survivors planning pregnancy, patients with carcinoid disease, patients with cardiac tumours and patients with right heart failure. Future directions and ongoing CV imaging research in cardio-oncology are discussed.
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.